New combo therapy aims to keep lung cancer from returning after surgery
NCT ID NCT06624059
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests the safety of combining the targeted drug alectinib with chemotherapy in people who have had surgery for a specific type of lung cancer (ALK-positive non-small cell lung cancer). The 11 participants received up to four cycles of the drug combo after their tumor was completely removed. The goal is to see if this approach can help control the disease without causing too many side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia
Perugia, Umbria, 06156, Italy
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Guangdong General Hospital
Guangzhou, 510000, China
-
Instituto do Cancer do Estado de Sao Paulo - ICESP
São Paulo, São Paulo, 01246-000, Brazil
-
Jinhua municipal central hospital
Jinhua, China
-
RedSalud Vitacura
Santiago, Chile
-
Royal North Shore Hospital
St Leonards, New South Wales, 2065, Australia
-
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009, Australia
-
The third people's hospital of Chengdu
Chengdu, China
-
Yunnan Cancer Hospital
Kunming, 650118, China